Compare Nasdaq100 ETF (QQQ) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nasdaq100 ETF vs Tempus AI — how do they compare? Nasdaq100 ETF trades at $754.36 (market cap $508.48B), while Tempus AI trades at $69.95 (market cap $12.77B). The key difference: Nasdaq100 ETF is far larger — about 39.8× Tempus AI's market cap, and Nasdaq100 ETF is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nasdaq100 ETF for 162 Days and Tempus AI for 22 Days on average.
| QQQ | TEM | |
|---|---|---|
Market Cap | $508.48B | $12.77B |
Volume | 25,184,775 | 8,980,490 |
52-Week High | $759.66 | $99.28 |
52-Week Low | $558.34 | $41.55 |
Typical Hold Time | 162 Days | 22 Days |
Sector | — | Broad Market / Factor |
Enterprise Value | — | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QQQ trades at $757.73, down 0.25% on the day, with a bullish technical signal from moving averages but bearish oscillators. Analyst sentiment is split evenly between buy and sell recommendations. The ETF's recent all-time high and concentrated tech exposure drive both optimism and valuation concerns amid AI-driven market trends.
The outlook hinges on tech sector performance and interest rate sensitivity. Opportunities include AI growth tailwinds, while risks involve high valuations and Fed policy impacts. A dividend of $0.75 is scheduled for October 2026, adding income appeal but not immediate catalyst.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nasdaq100 ETF
The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on QQQ →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
